Implications of Implementing the 2021 CKD-EPI Equation Without Race on Managing Patients With Kidney Disease in British Columbia, Canada by Mohammad Atiquzzaman, Lee Er, Ognjenka Djurdjev, Micheli Bevilacqua, Mark Elliott, Peter C. Birks, Michelle M.Y. Wong, Tae Won Yi, Anurag Singh, Navdeep Tangri, Adeera Levin

Get full text

Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community by Roberto Pecoits‐Filho, Michelle M.Y. Wong, Monica Moorthy, Debasish Banerjee, Suman Behera, Viviane Calice‐Silva, Mogamat‐Yazied Chothia, Gates B. Colbert, Martha Gulati, Charles A. Herzog, Fadi Jouhra, Edgar V. Lerma, Charu Malik, Kershaw V. Patel, Amina Rakisheva, Giuseppe M.C. Rosano, Priyanka Satish, Henry H.L. Wu, Angela Yee‐Moon Wang

Get full text

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community by Roberto Pecoits-Filho, MD, PhD, Michelle M.Y. Wong, MD, Monica Moorthy, MSc, Debasish Banerjee, MD, Suman Behera, MD, FRCPC, Viviane Calice-Silva, MD, PhD, Mogamat-Yazied Chothia, PhD, Gates B. Colbert, MD, Martha Gulati, MD, MS, Charles A. Herzog, MD, Fadi Jouhra, MD, Edgar V. Lerma, MD, Charu Malik, PhD, Kershaw V. Patel, MD, Amina Rakisheva, MD, Giuseppe M.C. Rosano, MD, PhD, Priyanka Satish, MD, Henry H.L. Wu, MBChB, Angela Yee-Moon Wang, MD, PhD

Get full text